Hemagglutination assay: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
(No difference)

Revision as of 15:33, 16 February 2012

WikiDoc Resources for Hemagglutination assay

Articles

Most recent articles on Hemagglutination assay

Most cited articles on Hemagglutination assay

Review articles on Hemagglutination assay

Articles on Hemagglutination assay in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemagglutination assay

Images of Hemagglutination assay

Photos of Hemagglutination assay

Podcasts & MP3s on Hemagglutination assay

Videos on Hemagglutination assay

Evidence Based Medicine

Cochrane Collaboration on Hemagglutination assay

Bandolier on Hemagglutination assay

TRIP on Hemagglutination assay

Clinical Trials

Ongoing Trials on Hemagglutination assay at Clinical Trials.gov

Trial results on Hemagglutination assay

Clinical Trials on Hemagglutination assay at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemagglutination assay

NICE Guidance on Hemagglutination assay

NHS PRODIGY Guidance

FDA on Hemagglutination assay

CDC on Hemagglutination assay

Books

Books on Hemagglutination assay

News

Hemagglutination assay in the news

Be alerted to news on Hemagglutination assay

News trends on Hemagglutination assay

Commentary

Blogs on Hemagglutination assay

Definitions

Definitions of Hemagglutination assay

Patient Resources / Community

Patient resources on Hemagglutination assay

Discussion groups on Hemagglutination assay

Patient Handouts on Hemagglutination assay

Directions to Hospitals Treating Hemagglutination assay

Risk calculators and risk factors for Hemagglutination assay

Healthcare Provider Resources

Symptoms of Hemagglutination assay

Causes & Risk Factors for Hemagglutination assay

Diagnostic studies for Hemagglutination assay

Treatment of Hemagglutination assay

Continuing Medical Education (CME)

CME Programs on Hemagglutination assay

International

Hemagglutination assay en Espanol

Hemagglutination assay en Francais

Business

Hemagglutination assay in the Marketplace

Patents on Hemagglutination assay

Experimental / Informatics

List of terms related to Hemagglutination assay

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The Hemagglutination Assay (HA) is a quantification of viruses.

Some viral families have surface or envelope proteins, that are able to agglutinate (stick to) human or animal Red blood cells (RBC) and bind to its N-acetylneuraminic acid. The RBC will form a type of lattice in this case.

In contrast to Plaque assay or LD50, HA does not give any measure of viral infectivity, because no virus replication is required in this assay.

It is an easy, simple and rapid method and can be applied to large amounts of samples.

The detailed conditions depend on the type of virus. Some viruses bind RBCs only at certain pH values, others at certain ionic strengths.

A virus dilution (eg. 2-fold from 1:4 to 1:4096) will be applied to a RBC dilution (eg. 0.1% to 0.7% in steps of 0.2%) for approx. 30 min, often at 4C, because else viruses with neuraminidase activity will detach the virus from the RBCs. Then the lattice forming parts will be counted and the titre calculated.

Virus concentration in virions per milliliter = 107 x HA titer.[1]

Related chapters

References

  1. Donald HB, Isaacs A (1954). "Counts of influenza virus particles". J. Gen. Microbiol. 10 (3): 457–64. PMID 13174769.

Template:SIB

Template:WikiDoc Sources Template:WH